Walleye Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$885K Sell
3,024
-106,159
-97% -$34.9M ﹤0.01% 2192
2025
Q4
$38.3M Buy
109,183
+86,115
+373% +$29.1M 0.12% 108
2025
Q3
$7.45M Buy
23,068
+12,011
+109% +$3.74M 0.03% 690
2025
Q2
$4.3M Buy
11,057
+3,031
+38% +$1.22M 0.02% 972
2025
Q1
$3.49M Sell
8,026
-3,726
-32% -$1.5M 0.02% 1027
2024
Q4
$4.34M Buy
11,752
+7,482
+175% +$3.13M 0.01% 1177
2024
Q3
$2.22M Buy
4,270
+4,060
+1,933% +$2.17M ﹤0.01% 1845
2024
Q2
$114K Sell
210
-4,962
-96% -$2.62M ﹤0.01% 4654
2024
Q1
$2.68M Sell
5,172
-23,033
-82% -$11.5M ﹤0.01% 1774
2023
Q4
$13.3M Buy
28,205
+19,970
+243% +$9.23M 0.03% 534
2023
Q3
$3.59M Buy
8,235
+3,675
+81% +$1.67M 0.01% 1283
2023
Q2
$2.03M Buy
4,560
+3,722
+444% +$1.72M 0.01% 1314
2023
Q1
$385K Buy
+838
New +$399K 0.01% 1921
2020
Q1
Sell
-822
Closed -$248K 1139
2019
Q4
$248K Sell
822
-424
-34% -$117K 0.02% 1016
2019
Q3
$299K Buy
+1,246
New +$341K 0.02% 982
2019
Q2
Sell
-825
Closed -$237K 1813
2019
Q1
$237K Buy
+825
New +$239K 0.04% 696
2018
Q3
$560K Buy
+2,044
New +$531K 0.26% 114

Other funds holding ELV

Walleye Capital's ELV Position: Q1 2026 in Review

Walleye Capital reduced its Elevance Health (ELV) stake by 97% in Q1 2026, selling an estimated $34.9M and leaving 3,024 shares worth $885K. The position accounts for ﹤0.01% of the portfolio, ranked #2192.

Walleye Capital first reported a position in ELV in Q3 2018 and has held it in 17 quarters since. The position peaked at $38.3M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Walleye Capital held 3,024 shares of Elevance Health worth $885K as of Q1 2026.
  • Walleye Capital sold 106,159 Elevance Health shares in Q1 2026, an estimated $34.9M.
  • Elevance Health made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2192 holding.
  • Walleye Capital first reported a position in Elevance Health in Q3 2018 and has held it in 17 quarters since.
  • Walleye Capital's Elevance Health position peaked at $38.3M in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.